A Cu2+ Probe over Nizatidine and Ranitidine, or In Silico Vs. Experimentally Obtained Complexation of Drugs

Article Preview

Abstract:

In silico model of title drugs mode of interaction with Cu2+ ion was proposed. A hundred conformations of each drug are used in this study. Examination of drugs interactions with Cu2+ ion were conducted using GRID package. The Cu2+ probe was used. The two favorable regions of interactions were detected: a) the nitro group and terminal imino nitrogen in a γ position from it, as proposed from the experimental data, b) the region of heterocyclic ring (tiazoline and furan from Nizatidine and Ranitidine, respectively) as the most favorable one. Therefore, the present study identifies the second region of the molecule that is able to strongly interact with the Cu2+ ion. The position and energies of obtained molecular interaction fields (MIF) are discussed. The results support the fact that the properties, which express recognition forces of the molecules, are strongly dependent on 3D geometry.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

435-439

Citation:

Online since:

September 2007

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2007 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] S.P. Sovilj, A. Džambaski and T. Jovanović: Asian Journal of Chemistry Vol. 15(1) (2003), p.19.

Google Scholar

[2] M. Mathur, S. Shrivastava and N.M. Shrivastava: Asian Journal of Chemistry Vol. 12(2) (2000), p.371.

Google Scholar

[3] Freely assessable at: http: /bioinformatics. charite. de/superdrug.

Google Scholar

[4] Catalyst 4, 7, distributed by Accelrys, San Diego CA, USA.

Google Scholar

[5] A. Pedretti, L. Villa and G. Vistoli: VEGA - An open platform to develop chemo-bioinformatics applications, using plug-in architecture and script programming: Jour. Comp. Aid. Mol. Des. Vol. 18(3) (2004), p.167; http: /www. ddl. unimi. it.

DOI: 10.1023/b:jcam.0000035186.90683.f2

Google Scholar

[6] a) GRID version 22b, distributed by Molecular Discovery Ltd., UK; For the GRID functionality, commands and options see the GRID manual @ http: /www. moldiscovery. com/docs/grid/; b) Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules: J. Med. Chem. Vol. 28(7) (1985).

DOI: 10.1021/jm00145a002

Google Scholar

[7] R.B. Silverman: The Organic Chemistry of the Drug Design and Drug Action (Elsevier 2004) pp.159-165; and cited references.

Google Scholar

[8] G. Vistoli, A. Pedretti, L. Villa and B. Testa: J. Med. Chem. Vol. 48(15) (2005), p.4947.

Google Scholar